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Background: The fetal time period is a critical window of immune system development and resulting heightened
susceptibility to the adverse effects of environmental exposures. Epidemiologists and toxicologists have hypothesized
that persistent organic pollutants, pesticides and metals have immunotoxic properties. Immunotoxic effects may manifest
as an altered immune system profile at birth. Immunoglobulin E, thymic stromal lymphopoietin (TSLP), and interleukin-33
(IL-33) may be implicated in the etiology of childhood allergy and are detectable at birth. The objective of this study was
to examine the potential relationship between maternal concentrations of metals, persistent organic pollutants, and
pesticides and elevated umbilical cord blood concentrations of IgE, TSLP, and IL-33 in a Canadian birth cohort.
Methods: This study utilized data collected in the Maternal-Infant Research on Environmental Chemicals (MIREC) Study, a
trans-Canada cohort study of 2,001 pregnant women. Of these women, 1258 had a singleton, term birth and cord blood
sample. Logistic regression was used to determine associations between log-transformed continuous variables and
immune system biomarkers.
Results: Inverse relationships were observed between lead, DDE, PCB-118, and a summary index of organophosphorous
metabolites and jointly elevated concentrations of IL-33 and TSLP. None of the environmental contaminants were
associated with increased odds of a high cord blood immune system biomarker concentration.
Conclusions: In this primarily urban Canadian population of pregnant women and their newborns, maternal blood or
urine concentrations of persistent organic pollutants, pesticides, and metals were not associated with immunotoxic
effects that manifest as increased odds of elevated concentrations of IgE, TSLP or IL-33.
Keywords: Persistent organic pollutants, Metals, Pesticides, Immunoglobulin E, Thymic stromal lymphopoietin,
Interleukin-33, Pregnancy, CohortBackground
In utero exposures to certain environmental contaminants
can trigger permanent, irreversible changes to the devel-
oping immune system. These changes may promote the
persistence of skewed immune system responses and sub-
sequent increased risk of an allergic phenotype [1–3].
Toxicologists and epidemiologists have hypothesized
that metals [1, 4, 3], pesticides [5, 6], and polychlorinated
biphenyls (PCBs) [7, 8] have immunotoxic properties.* Correspondence: l.dodds@dal.ca
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creativecommons.org/publicdomain/zero/1.0/The majority of North Americans have detectable blood
concentrations of metals [9, 10]. Organophosphate pesti-
cide exposure is common, even in urban populations,
due to ingestion of pesticide residues on treated food
[11] and presence in household dust [12]. Many adults
have detectable concentrations of persistent organic
pollutants (POPs), including polychlorinated biphenyls
(PCBs) [13] and certain organochlorine pesticides [14]
due to their lipophilic and persistent nature [10].
In utero environmental contaminant exposure may be
associated with altered levels of immune system bio-
markers at birth and possible subsequent risk of childhood
allergy [15, 16]. The immune system biomarkers, im-
munoglobulin E (IgE), interleukin-33 (IL-33) and thymiccess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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birth [17] and are integral in the mechanisms underlying
allergic responses [18]. Cord blood IgE concentrations
have been previously used as a biomarker of the immuno-
toxic effects of in utero environmental contaminant expos-
ure [19–22]. TSLP and IL-33 have recently been
recognized for their etiologic role in atopic dermatitis, the
earliest manifestation of childhood allergy [23]. TSLP has
also been recently recognized for its role in childhood al-
lergy [24]. Unlike lymphopoietic cell- derived Th2 cyto-
kines, TSLP and IL-33 are produced by epithelial cells
and, therefore, not dependent on the presence of a mature
immune system [25]. Moreover, epithelial cells have re-
cently been recognized for their role in the regulation of
innate and adaptive immune system responses [26, 27]. By
lining the digestive, respiratory tract, and skin, epithelial
cells may represent the point of entry for environmental
contaminant exposure [28].
The objective of the present study was to determine the
association between maternal concentrations of pesticides,
PCBs, and metals and elevated cord blood concentrations
of IgE, TSLP, and IL-33 using data from a Canadian birth
cohort. A secondary objective was to assess whether these
associations differed by infant sex [29].
Methods
Study population
Data and biospecimens were obtained from the Maternal-
Infant Research on Environmental Chemicals (MIREC)
Study, a trans-Canada cohort study of 2,001 pregnant
women from ten Canadian cities recruited between 2008
and 2011 [30]. The target population and exclusion cri-
teria for the MIREC study and present analysis have been
described previously [17, 30]. Cord blood samples that
were determined to be contaminated with maternal blood
based on an elevated immunoglobulin A (IgA) concentra-
tion (≥10 μg/mL) were excluded from the analysis [31]. As
pre-term and multiple birth infants had lower cord blood
samples of the immune system biomarkers and may have
a differing allergic disease risk profile [32, 33], these sam-
ples were excluded. This study received ethical approval
from Health Canada, St. Justine’s Hospital (Montreal,
QC), and the IWK Health Centre (Halifax, NS) and all
participants provided consent.
Environmental Contaminant Exposure
In the present investigation, four organochlorine pesti-
cides, four PCB congeners, five organophosphate pesticide
metabolites, and four metals were analyzed. These or-
ganochlorine pesticides and PCB congeners were mea-
sured in first trimester plasma (Table 1). The non-dioxin
like PCB congeners 138, 153, and 180 were summed to
create an index of PCB exposure. Plasma samples were
analyzed by gas chromatography coupled to a massspectrometer (Agilent 6890 N/5973 GC-MS). The organo-
phosphate pesticide metabolites were measured in first tri-
mester urine (Table 1). Index measures of the dimethyl
alkylphosphate (DMAP) and diethyl alkylphosphate
(DEAP) metabolites were calculated by summing the
respective metabolites on a molar basis [34]. As only 2 %
of samples had detectable concentrations of the organo-
phosphate metabolite DEDTP, this metabolite was not
analysed. Organophosphate metabolites in urine were
measured with a GC-MS-MS instrument with a GC
Agilent6890 N (Agilent Technologies; Mississauga, ON,
Canada) coupled with a tandem mass spectrometer
Quattro Micro GC (Waters; Milford, Massachusetts, USA).
First and third trimester whole blood metals (lead,
mercury, arsenic, and cadmium) concentrations were
averaged to create an index of exposure throughout
pregnancy. Metal concentrations were analyzed using
inductively coupled plasma mass spectrometry (Perki-
nElmer ELAN ICP-MS DRC II). All chemical analyses of
blood and urine samples were carried out at the Toxicol-
ogy Centre of the Quebec Institute of Public Health,
accredited by the Standards Council of Canada.
Fetal Immune System Markers
Immune system biomarkers were measured in the
plasma of umbilical cord blood samples (details in [17]).
TSLP concentrations were determined using a commer-
cial antibody kit (Biolegend, San Diego, CA, USA). IL-33
concentrations were analyzed using antibodies from an
R & D systems duoset (Minneapolis, MN, USA). ELISA
kits (EBioscience, San Diego, CA, USA) were also used
to assess both total IgE and IgA concentrations.
Statistical Analysis
For the descriptive statistics, urinary concentrations of
the organophosphate metabolites were adjusted for
specific gravity to account for heterogeneity in urinary
dilution according to the following formula Pc = Pi
[(SGm- 1)/(SGi - 1)], where: Pc = SG adjusted metabolite
concentration (μg/ml), Pi = observed metabolite concen-
tration,, SGi = specific gravity of the urine sample, and
SGm =median SG for the cohort [35].
Due to the high percentage of cord blood samples
below the limit of detection (LOD), each immune system
biomarker was categorized into a binary variable. A
composite variable was developed to identify samples
with elevated concentrations of both TSLP and IL-33
(IL-33/TSLP) as these cytokines are highly correlated
(Spearman correlation coefficient = 0.8) and known to
interact in experimental models [26]. Elevated concen-
trations of TSLP and IL-33 were defined as samples that
exceeded the 80th percentile for both cytokines (TSLP =
554 pg/mL; IL-33 = 879 pg/mL) because there are no
pre-existing thresholds. Elevated IgE samples were
Table 1 Descriptive statistics of environmental contaminants (MIREC study, 2008–2011)
Chemical (μg/L) N LOD %>LOD Min Median Max IQR
Organochlorine Pesticides (plasma)
Trans-nonachlor 1232 0.01 84.58 LOD 0.02 0.23 0.01
p,p'-Dichlorodiphenyldichloroethylene (DDE) 1233 0.09 99.19 LOD 0.30 26.00 0.28
Hexachlorobenzene 1232 0.04 29.71 LOD 0.02 0.61 0.02
Oxychlordane 1231 0.005 92.04 LOD 0.01 0.13 0.01
Organophosphate Pesticide Metabolites(urine)a
Dimethylphosphate (DMP) 1229 1.00 79.55 LOD 3.25 43.33 4.44
Dimethylthiphosphate (DMTP) 1227 0.60 80.49 LOD 3.44 141.82 7.22
Diethyldithiophosphate (DEDTP) 1230 0.30 2.27 LOD 0.15 4.02 0.18
Diethylthiophosphate (DETP) 1229 0.3,0.6 52.92 LOD 0.65 31.89 0.85
Diethylphosphate (DEP) 1230 1.00 76.64 LOD 2.38 2104.76 2.90
Polychlorinated biphenyls (plasma)
PCB 118 1233 0.01 74.45 LOD 0.01 0.22 0.02
PCB 138 1233 0.01 93.19 LOD 0.03 0.28 0.02
PCB 153 1233 0.01 99.19 LOD 0.04 0.53 0.04
PCB 180 1233 0.01 92.70 LOD 0.03 0.77 0.03
Metals (whole blood)
Lead (μg/dL) 1241 0.10 100.00 0.17 0.62 4.14 0.41
Cadmium 1241 0.04 97.42 LOD 0.20 5.06 0.17
Arsenic 1241 0.22 93.63 LOD 0.82 34.46 0.66
Mercury 1241 0.12,0.10 90.57 LOD 0.70 10.03 1.02
aadjusted for specific gravity [41]
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cut-off point previously used in studies of cord blood
IgE [36, 37].
Logistic regression was employed to estimate the associ-
ation between log-transformed continuous variables and
elevated concentrations of IgE and IL-33/TSLP with the
exception of hexachlorobenzene. Due to the high percent-
age of samples below the LOD for this chemical, a binary
variable categorized at the LOD was created. For all other
chemicals, maximum likelihood estimation was used, as-
suming a log-normal distribution for sample concentra-
tions. This method of accounting for samples with values
below the LOD is less prone to bias than substitution
methods that use LOD/2 or LOD/√2 [38]. For environ-
mental contaminants with 2 LODs (e.g. mercury, DETP),
all values less than the higher LOD were treated as below
the limit of detection. For the summary measures of PCBs
congeners and organophosphate metabolites, a value was
treated as less than the LOD if each of the individual
metabolite values were undetectable.
Potential covariates were identified based on previous
literature of predictors of the environmental contaminant
exposures (organochlorine pesticides [39], organophos-
phorous pesticides [40], PCBs [41], metals [42–44]) and
predictors of the immune system biomarkers [17, 45].Maternal blood lipid concentrations were included in the
organochlorine and PCB models to account for the lipo-
philic nature of these chemicals and intra-individual het-
erogeneity in lipids [46]. Maternal urinary specific gravity
was included into the organophosphate pesticide metabol-
ite models to account for heterogeneity in urinary dilution
[47]. Maternal age was a priori entered into all models; no
predictors of both exposure and outcome were identified.
The linearity of the relationship between each environ-
mental contaminant and immune system biomarker was
assessed using restricted cubic splines [48]. To assess
whether relationships differed by infant sex, the P-value of
the sex*exposure interaction term was assessed and sex-
stratified analyses were conducted. For statistically signifi-
cant associations, two additional analyses were conducted
using; i) tertiles of exposure and ii) a doubling of exposure
concentrations. This was done for ease of interpretation
and visualization of results. A linear test for trend was per-
formed to evaluate dose–response relationships between
tertiles of exposure and the immune system biomarker of
interest; resulting P-values were reported.
Results
Of the 2,001 women recruited, 18 withdrew and asked
that all their data and biospecimens be destroyed. Of the
Table 2 Study participant characteristics, MIREC Study, Canada,



















Maternal Reproductive & Medical History
Pre-Pregnancy BMIc
Underweight (<18.5) 27 2.3
Normal (18.5 to 24.9) 717 60.5
Overweight (25 to 29.9) 272 22.9















2500- < 3500 606 48.2
3500- < 4000 448 35.7
≥4000 192 15.3
aSubtotals may not sum to total due to missing data, bdefined as either the
mother or father smoking during pregnancy, cWorld Health Organization
Classification [66], dDefined as maternal use of allergy medication
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sample. Of these 1,363 samples, 107 were excluded for
missing chemical exposure data, a high IgA concentration,
pre-term birth (<37 weeks), multiple birth, or samples
with insufficient sample for analysis. Among the eligible
subset of study participants (term, singleton births), there
were no notable differences between women with and
without a cord blood sample in regard to parental smok-
ing, maternal age, or BMI. Seventy-three percent of the
eligible participants in the cohort had a cord blood sample
that was included in the analytical sample.
Table 1 shows descriptive statistics of the environmental
contaminants. The percentage of samples above the limit
of detection ranged from 29.7 % for hexachlorobenzene to
100 % for lead. Maternal demographic, reproductive, and
infant characteristics are depicted in Table 2. The majority
of study participants were 30 years or older, had a house-
hold income greater than $50,000, were non-smokers, and
of normal BMI.
As no chemical met the criteria for non-linearity, all ex-
posures were entered into the model as continuous vari-
ables without a quadratic term. Results of the IL-33/TSLP
and IgE models are presented in Tables 3 and 4 respect-
ively. All models were adjusted for age and, depending on
the specific chemical, specific gravity or lipids. Significant
inverse associations were observed between maternal lead
concentrations, DDE concentrations, PCB 118 concentra-
tions, ∑DEP and DETP concentrations and elevated con-
centrations of IL-33/TSLP (lead aOR = 0.70 95 % CI: 0.48-
0.94; DDE aOR = 0.81 95 % CI: 0.63-0.98; PCB 118 aOR =
0.69 95 % CI: 0.40-0.98; ∑DEP and DETP aOR = 0.85 95 %
CI: 0.72-0.97). No significant associations were observed
between any of the environmental contaminants and
elevated cord blood concentrations of IgE. There was no
observed effect modification by sex or material differences
in the sex-stratified analysis (data not shown).
Table 5 depicts the results of the tertile analysis for che-
micals with significant associations in the analyses using
continuous exposures. Results were consistent with the
analysis of continuous exposures though none of the effect
measures achieved statistical significance. A suggestion of
an inverse finding was observed in the relationship be-
tween both DDE and PCB 118 and IL-33/TSLP (P-value
test for trend = 0.06 for both contaminants). A two fold in-
crease in log maternal lead, PCB 118, DDE and ∑DEP and
DETP concentrations was associated with odds ratios com-
parable to the analysis using continuous exposures and ter-
tiles (lead aOR = 0.80 95 % CI:0.63-1.00; DDE aOR =0.86
95 % CI:0.74-1.00; PCB 118 aOR = 0.78 95 % CI:0.58-1.03;
∑DEP and DETP aOR = 0.91 95 % CI: 0.80-1.04).
Discussion
In this study, we sought to characterize the association be-
tween prenatal exposure to PCBs, pesticides and metals
Table 3 Odds ratio of log10 maternal contaminant
concentrations and elevated (≥80 %) cord blood concentrations
of IL-33/TSLP





Trans-nonachlor 1232 0.83 (0.61-1.07) 0.77 (0.46-1.08)
DDE 1233 0.80 (0.64-0.97) 0.81 (0.63-0.98)
Hexachlorobenzene
(binary)
1232 0.79 (0.56-1.10) 0.79 (0.56-1.14)





1229 0.86 (0.75-0.97) 0.85 (0.68-1.02)
Dimethylthiphosphate
(DMTP)
1227 0.99 (0.89-1.08) 0.98 (0.84-1.12)
Diethylthiophosphate
(DETP)
1229 0.95 (0.81-1.09) 0.96 (0.72-1.22)
Diethylphosphate (DEP) 1230 0.85 (0.73-0.97) 0.87 (0.67-1.06)
ƩDMP&DMTP 1226 0.90 (0.79-1.02) 0.91 (0.80-1.03)
ƩDEP&DETP 1229 0.85 (0.72-0.98) 0.85 (0.72-0.97)
Polychlorinated biphenylsa
PCB 118 1233 0.83 (0.62-1.05) 0.69 (0.40-0.98)
PCB 138 1233 0.85 (0.67-1.05) 0.86 (0.62-1.10)
PCB 153 1233 0.87 (0.68-1.06) 0.86 (0.65-1.08)
PCB 180 1233 0.87 (0.70-1.04) 0.95 (0.72-1.19)
ƩPCB (non-dioxin –
138,153,180)
1233 0.87 (0.68-1.07) 0.89 (0.67-1.11)
Metalsc
Lead 1241 0.70 (0.48-0.94) 0.72 (0.48-0.95)
Cadmium 1241 0.91 (0.73-1.10) 0.92 (0.73-1.11)
Arsenic 1241 0.94(0.73-1.14) 0.95 (0.73-1.17)
Mercury 1241 0.94 (0.80-1.07) 0.96 (0.82-1.10)
aadjusted for age and lipids, badjusted for age and specific gravity, cadjusted
for age
Table 4 Odds ratio of log10 maternal contaminant
concentrations and elevated (≥0.5 ku/L) cord blood
concentrations of IgE






Trans-nonachlor 1232 0.81 (0.59-1.03) 0.86 (0.51-1.10)
DDE 1233 0.93 (0.75-1.12) 1.00 (0.79-1.20)
Hexachlorobenzene
(binary)
1232 0.87 (0.62-1.20) 0.89 (0.62-1.27)





1229 0.97 (0.85-1.10) 1.01 (0.81-1.21)
Diethylphosphate (DEP) 1230 0.91 (0.78-1.04) 0.88 (0.69-1.08)
Dimethylthiphosphate
(DMTP)
1227 0.98 (0.88-1.07) 0.92 (0.79-1.06)
Diethylthiophosphate
(DETP)
1229 0.99 (0.84-1.13) 0.95 (0.70-1.19)
ƩDMP&DMTP 1226 0.96 (0.84-1.08) 1.00 (0.81-1.11)
ƩDEP&DETP 1229 0.95 (0.81-1.09) 0.86 (0.70-1.01)
Polychlorinated biphenylsa
PCB 118 1233 0.98 (0.74-1.23) 1.08 (0.68-1.49)
PCB 138 1233 0.96 (0.75-1.17) 1.11 (0.81-1.40)
PCB 153 1233 0.96 (0.76-1.17) 1.08 (0.82-1.33)
PCB 180 1233 0.93 (0.75-1.11) 1.07 (0.82-1.33)
ƩPCB (non-dioxin –
138,153,180)
1233 0.95 (0.74-1.16) 1.07 (0.81-1.33)
Metalsc
Lead 1241 0.92 (0.63-1.23) 0.98 (0.66-1.30)
Cadmium 1241 0.90 (0.72-1.09) 0.91 (0.73-1.10)
Arsenic 1241 1.16 (0.90-1.41) 1.20 (0.93-1.47)
Mercury 1241 0.95 (0.81-1.09) 1.00 (0.84-1.15)
aadjusted for age and lipids, badjusted for age and specific gravity, cadjusted
for age
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observed inverse associations between maternal lead, PCB
118, DDE, ∑DEP and DETP and IL-33/TSLP. No effect
modification by sex was observed in these relationships.
Our findings suggest that contemporary maternal concen-
trations of these environmental contaminants are not as-
sociated with developmental immunotoxicity as measured
by the immune system biomarkers of interest.
Experimental evidence has demonstrated that gesta-
tional lead exposure may elevate IgE concentrations [3, 49]
and enhance Th2 cell responses [50]. A significantly ele-
vated risk of childhood atopy was observed among chil-
dren with elevated maternal and cord blood lead
concentrations in a Polish birth cohort [51]. Significant
correlations between childhood lead concentrations andboth elevated IgE [52–54] and atopic dermatitis [55] have
been identified in cross-sectional analyses. In light of these
previous findings, the observed lack of association be-
tween lead and IgE an inverse association between lead
and IL-33/TSLP in the present study was unexpected.
There is experimental evidence that PCBs may en-
hance production of Th2 cell cytokines involved in aller-
gic responses [8]. Similar associations have not, however,
been consistently observed in epidemiologic studies. For
example, a meta-analysis of ten European cohort studies
concluded that prenatal PCB-153 exposure was not
associated with infant wheeze or bronchitis [56].
Conversely, authors of a recent Dutch cohort study re-
ported a positive association between prenatal PCB-153
Table 5 Odds ratios of tertiles of exposure and elevated (≥80 %)
cord blood concentrations of IL-33/TSLP for contaminants shown
to have significant associations from Table 2
Contaminant Tertiles Adjusted OR (95 % CI)
DDEa (ug/L) ≤0.23 1.0
(n = 1233) 0.24-0.39 0.75 (0.51-1.09)
>0.39 0.69 (0.47-1.02)
P-value test for trend 0.06
PCB 118a (ug/L) ≤0.011 1.0
(n = 1233) 0.011-0.018 0.85 (0.58-1.23)
>0.018 0.67 (0.45-1.02)
P-value test for trend 0.06
ƩDEP&DETPbb(ug/L) ≤12.60 1.0
(n = 1229) 12.61-26.90 0.84 (0.57-1.24)
>26.90 0.89 (0.56-1.40)
P-value test for trend 0.08
Leadc (ug/dL) ≤0.68 1.0
(n = 1241) 0.69-1.08 0.83 (0.57-1.20)
>1.08 0.77 (0.53-1.11)
P-value test for trend 0.16
aadjusted for age and lipids, badjusted for age and specific gravity, cadjusted
for age
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tween the ages of 6 and 20 [57].
Experimental evidence has also demonstrated that or-
ganochlorine pesticide exposure, specifically DDE, may
also induce allergic type responses via enhanced produc-
tion of Th2 cytokines [6]. Though positive associations be-
tween prenatal DDE exposure and measures of childhood
allergic disease have been reported in two birth cohort
studies [58, 59], a meta-analysis of 10 cohort studies re-
ported that this association was limited to children less
than 18 months old [56]. In addition, authors of the Dutch
cohort study reported no significant association between
prenatal DDE exposure (median = 2.47 ng/mL) and asthma
medication use [57]. While organophosphorous pesticides
may alter immune system function [6], we did not identify
any birth cohort studies of maternal organophosphorous
pesticides exposures and childhood allergic outcomes.
In light of this literature, two primary factors may
explain the present findings. First, compared to historical
cohorts [51, 57], maternal environmental contaminant con-
centrations in the MIREC study are relatively low. Average
lead concentrations in the MIREC study (geometric
mean = 0.88 μg/dL) were lower than observed in the
Polish birth cohort (geometric mean = 1.60 μg/dL) [51]
and notably lower than 1 to 2 ug/dL, values which have
been reported to be associated with adverse health effects
[60]. Maternal concentrations of PCB-153 and DDE
were also lower among MIREC participants than in the
Dutch cohort study (PCB-153 median = 1.37 μg/L, DDEmedian = 0.3 μg/L) [57]. Second, it possible that the ob-
served inverse associations may be a product of live birth
bias [61]. Fetuses that were most susceptible to the toxic
effects of contaminant exposure may not have survived
until birth. The term fetuses in the present analysis may,
therefore, represent a ‘healthy’ subset of the total number
of pregnancies among MIREC study participants.
Our study was also subject to the following four limita-
tions. First, although the persistent organic pollutants and
metals have long half-lives and, therefore, little expected
variation throughout pregnancy, the organophosphorous
metabolites have relatively short half-lives [62] and may
vary during pregnancy [63]. Furthermore, first trimester
urinary measures may not be representative of exposure
during critical windows of immune system development.
Considering that 1) that exposure misclassification is non-
differential and 2) this study employed continuous rather
than polytomous exposure variables, any potential mis-
classification bias likely attenuated effect estimates to-
wards the null [64]. Second, due to the limited literature
regarding IL-33 and TSLP at birth, our choice of cut-off
points was not based on clinical guidelines. Rather, we
based this cut-off on our previous analysis of predictors of
elevated concentrations of IL-33 and TSLP at birth [17].
In the present analysis, we conducted a sensitivity analysis
for chemicals with statistically significant associations by
dichotomizing IL-33 and TSLP at the limit of detection.
As we observed similar odds ratios when using the limit
of detection cut-off, we have only reported results using
the 80th percentile cut-off. Third, as we did not have clin-
ical data on asthma development in the children, it is not
possible to determine the clinical implications of our find-
ings. Fourth, the present results may be subject to negative
confounding by an unmeasured protective factor for
allergy, such as maternal vitamin D [65].
Despite these limitations, this study benefited from the
relatively large sample size and the comparatively rich co-
variate data. Considering the relatively long-half life for the
persistent organic pollutants, there is unlikely to be consid-
erable within-person variability in exposure throughout
pregnancy. The value of the present research will become
most evident when combined with follow-up studies of
MIREC participants into childhood. In conjunction with
such follow-up, this research will help determine the timing
of any potential immunotoxic effect of in utero exposures
and may, ultimately, strengthen understanding of the devel-
opmental origins of childhood allergy. This information is
relevant to identifying critical windows of exposure and ul-
timately, to developing public health messages regarding
minimizing environmental contaminant exposure.
Conclusions
In this primarily urban Canadian population of pregnant
women and their newborns, maternal concentrations of
Ashley-Martin et al. Environmental Health  (2015) 14:52 Page 7 of 8persistent organic pollutants, pesticides, and metals
were not associated with elevated IgE, TSLP or IL-33.
Generalization of these findings beyond the MIREC study
population would require examination in a population of
differing socioeconomic status, ethnicity, or health profiles
(e.g. smoking and obesity rates). Future studies that exam-
ine the trajectory of these biomarkers from birth to child-
hood will complement the present findings.
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